Global Research Antibodies & Reagents Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

Description

List of Tables

The global demand for Research Antibodies & Reagents Market is presumed to reach the market size of nearly USD 22.66 Billion by 2032 from USD 11.97 Billion in 2023 with a CAGR of 7.35% under the study period 2024 - 2032.

Research antibodies & reagents are essential tools in the scientific study of biological processes, diseases, and cellular mechanisms. Antibodies specifically designed to bind to unique antigens allow researchers to detect and quantify specific proteins or molecules within complex biological samples. Reagents, including buffers, stains, and other chemical compounds, facilitate various experimental techniques such as immunohistochemistry, ELISA, and Western blotting. Together, these products enable detailed investigation and analysis in biomedical research, contributing to advancing knowledge and developing new therapeutic strategies.

MARKET DYNAMICS

The rise in demand for high-quality antibodies for research reproducibility is one of the major factors driving the growth of the research antibodies and reagents market. Moreover, rising investment in medical and health R&D is expected to fuel growth in the research antibodies and reagents market. The growing applications of biosciences and biotechnology in healthcare and pharmaceutical fields are driving demand. Furthermore, increased investment in the life sciences industry is driving up the need for research antibodies and reagents. Additionally, the increase in industry-academia collaboration and rising stem cell and neurobiology research field further influences the research antibodies and reagents market. However, the high cost and time related to identifying and developing potential antibodies are expected to hamper the market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Research Antibodies & Reagents. The growth and trends of Research Antibodies & Reagents industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Research Antibodies & Reagents market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

Reagent (Media & Sera, Stains & Dyes, Fixatives, Buffers, Solvents, Enzymes, Probes, Other Reagents)
Antibodies

By Type

Primary Antibodies
Secondary Antibodies

By Form

Monoclonal
Polyclonal
Recombinant

By Source

Mice
Rabbits
Other Sources

By Research Area

Oncology
Infectious Diseases
Immunology
Neurobiology
Stem Cells
Other Research Areas

By Technology

Western Blotting
Flow Cytometry
Enzyme-Linked Immunosorbent Assay (Elisa)
Immunohistochemistry
Immunofluorescence
Immunoprecipitation
Other Technologies

By Application

Proteomics
Drug Development
Genomics

By End User

Pharmaceutical & Biotechnologies Industries
Academic & Research Institutions
Contract Research Organizations

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Research Antibodies & Reagents market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Research Antibodies & Reagents market include Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Abcam Plc (UK), Becton, Dickinson, Company (US), Bio-Rad Laboratories (US), Cell Signaling Technology (US), F. Hoffmann-La Roche (Switzerland), Danaher Corporation (US), Agilent Technologies (US), PerkinElmer (US), Lonza (Switzerland), GenScript (China), BioLegend (US). This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Product Code: VMR11218746

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . RESEARCH ANTIBODIES & REAGENTS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product
- 3.7.2 Market Attractiveness Analysis By Type
- 3.7.3 Market Attractiveness Analysis By Form
- 3.7.4 Market Attractiveness Analysis By Source
- 3.7.5 Market Attractiveness Analysis By Research Area
- 3.7.6 Market Attractiveness Analysis By Technology
- 3.7.7 Market Attractiveness Analysis By Application
- 3.7.8 Market Attractiveness Analysis By End User
- 3.7.9 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SALES BY PRODUCT

5.1 Overview by Product
5.2 Historical and Forecast Sales Data
5.3 Analysis by Product
5.4 Reagent (Media & Sera, Stains & Dyes, Fixatives, Buffers, Solvents, Enzymes, Probes, Other Reagents) Historic and Forecast Sales by Regions
5.5 Antibodies Historic and Forecast Sales by Regions

6 . GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET ANALYSIS BY TYPE

6.1 Overview by Type
6.2 Historical and Forecast Sales Data
6.3 Analysis by Type
6.4 Primary Antibodies Historic and Forecast Sales by Regions
6.5 Secondary Antibodies Historic and Forecast Sales by Regions

7 . GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET ANALYSIS BY FORM

7.1 Overview by Form
7.2 Historical and Forecast Sales Data
7.3 Analysis by Form
7.4 Monoclonal Historic and Forecast Sales by Regions
7.5 Polyclonal Historic and Forecast Sales by Regions
7.6 Recombinant Historic and Forecast Sales by Regions

8 . GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET ANALYSIS BY SOURCE

8.1 Overview by Source
8.2 Historical and Forecast Sales Data
8.3 Analysis by Source
8.4 Mice Historic and Forecast Sales by Regions
8.5 Rabbits Historic and Forecast Sales by Regions
8.6 Other Sources Historic and Forecast Sales by Regions

9 . GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET ANALYSIS BY RESEARCH AREA

9.1 Overview by Research Area
9.2 Historical and Forecast Sales Data
9.3 Analysis by Research Area
9.4 Oncology Historic and Forecast Sales by Regions
9.5 Infectious Diseases Historic and Forecast Sales by Regions
9.6 Immunology Historic and Forecast Sales by Regions
9.7 Neurobiology Historic and Forecast Sales by Regions
9.8 Stem Cells Historic and Forecast Sales by Regions
9.9 Other Research Areas Historic and Forecast Sales by Regions

10 . GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET ANALYSIS BY TECHNOLOGY

10.1 Overview by Technology
10.2 Historical and Forecast Sales Data
10.3 Analysis by Technology
10.4 Western Blotting Historic and Forecast Sales by Regions
10.5 Flow Cytometry Historic and Forecast Sales by Regions
10.6 Enzyme-Linked Immunosorbent Assay (Elisa) Historic and Forecast Sales by Regions
10.7 Immunohistochemistry Historic and Forecast Sales by Regions
10.8 Immunofluorescence Historic and Forecast Sales by Regions
10.9 Immunoprecipitation Historic and Forecast Sales by Regions
10.1 Other Technologies Historic and Forecast Sales by Regions

11 . GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET ANALYSIS BY APPLICATION

11.1 Overview by Application
11.2 Historical and Forecast Sales Data
11.3 Analysis by Application
11.4 Proteomics Historic and Forecast Sales by Regions
11.5 Drug Development Historic and Forecast Sales by Regions
11.6 Genomics Historic and Forecast Sales by Regions

12 . GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET ANALYSIS BY DRUG DEVELOPMENT

12.1 Overview by End User
12.2 Historical and Forecast Sales Data
12.3 Analysis by End User
12.4 Pharmaceutical & Biotechnologies Industries Historic and Forecast Sales by Regions
12.5 Academic & Research Institutions Historic and Forecast Sales by Regions
12.6 Contract Research Organizations Historic and Forecast Sales by Regions

13 . GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET ANALYSIS BY GEOGRAPHY

13.1. Regional Outlook
13.2. Introduction
13.3. North America Sales Analysis
- 13.3.1. Overview, Historic and Forecast Data Sales Analysis
- 13.3.2. North America By Segment Sales Analysis
- 13.3.3. North America By Country Sales Analysis
- 13.3.4. United State Sales Analysis
- 13.3.5. Canada Sales Analysis
- 13.3.6. Mexico Sales Analysis
13.4. Europe Sales Analysis
- 13.4.1. Overview, Historic and Forecast Data Sales Analysis
- 13.4.2. Europe by Segment Sales Analysis
- 13.4.3. Europe by Country Sales Analysis
- 13.4.4. United Kingdom Sales Analysis
- 13.4.5. France Sales Analysis
- 13.4.6. Germany Sales Analysis
- 13.4.7. Italy Sales Analysis
- 13.4.8. Russia Sales Analysis
- 13.4.9. Rest Of Europe Sales Analysis
13.5. Asia Pacific Sales Analysis
- 13.5.1. Overview, Historic and Forecast Data Sales Analysis
- 13.5.2. Asia Pacific by Segment Sales Analysis
- 13.5.3. Asia Pacific by Country Sales Analysis
- 13.5.4. China Sales Analysis
- 13.5.5. India Sales Analysis
- 13.5.6. Japan Sales Analysis
- 13.5.7. South Korea Sales Analysis
- 13.5.8. Australia Sales Analysis
- 13.5.9. South East Asia Sales Analysis
- 13.5.10. Rest Of Asia Pacific Sales Analysis
13.6. Latin America Sales Analysis
- 13.6.1. Overview, Historic and Forecast Data Sales Analysis
- 13.6.2. Latin America by Segment Sales Analysis
- 13.6.3. Latin America by Country Sales Analysis
- 13.6.4. Brazil Sales Analysis
- 13.6.5. Argentina Sales Analysis
- 13.6.6. Peru Sales Analysis
- 13.6.7. Chile Sales Analysis
- 13.6.8. Rest of Latin America Sales Analysis
13.7. Middle East & Africa Sales Analysis
- 13.7.1. Overview, Historic and Forecast Data Sales Analysis
- 13.7.2. Middle East & Africa by Segment Sales Analysis
- 13.7.3. Middle East & Africa by Country Sales Analysis
- 13.7.4. Saudi Arabia Sales Analysis
- 13.7.5. UAE Sales Analysis
- 13.7.6. Israel Sales Analysis
- 13.7.7. South Africa Sales Analysis
- 13.7.8. Rest Of Middle East And Africa Sales Analysis

14 . COMPETITIVE LANDSCAPE OF THE RESEARCH ANTIBODIES & REAGENTS COMPANIES

14.1. Research Antibodies & Reagents Market Competition
14.2. Partnership/Collaboration/Agreement
14.3. Merger And Acquisitions
14.4. New Product Launch
14.5. Other Developments

15 . COMPANY PROFILES OF RESEARCH ANTIBODIES & REAGENTS INDUSTRY

15.1. Company Share Analysis
15.2. Market Concentration Rate
15.3. Thermo Fisher Scientific Inc. (US)
- 15.3.1. Company Overview
- 15.3.2. Company Revenue
- 15.3.3. Products
- 15.3.4. Recent Developments
15.4. Merck KGaA (Germany)
- 15.4.1. Company Overview
- 15.4.2. Company Revenue
- 15.4.3. Products
- 15.4.4. Recent Developments
15.5. Abcam Plc (UK)
- 15.5.1. Company Overview
- 15.5.2. Company Revenue
- 15.5.3. Products
- 15.5.4. Recent Developments
15.6. Becton, Dickinson Company (US)
- 15.6.1. Company Overview
- 15.6.2. Company Revenue
- 15.6.3. Products
- 15.6.4. Recent Developments
15.7. BioLegend (US)
- 15.7.1. Company Overview
- 15.7.2. Company Revenue
- 15.7.3. Products
- 15.7.4. Recent Developments
15.8. GenScript (China)
- 15.8.1. Company Overview
- 15.8.2. Company Revenue
- 15.8.3. Products
- 15.8.4. Recent Developments
15.9. Bio-Rad Laboratories (US)
- 15.9.1. Company Overview
- 15.9.2. Company Revenue
- 15.9.3. Products
- 15.9.4. Recent Developments
15.10. Cell Signaling Technology (US)
- 15.10.1. Company Overview
- 15.10.2. Company Revenue
- 15.10.3. Products
- 15.10.4. Recent Developments
15.11. F. Hoffmann-La Roche (Switzerland)
- 15.11.1. Company Overview
- 15.11.2. Company Revenue
- 15.11.3. Products
- 15.11.4. Recent Developments
15.12. Danaher Corporation (US)
- 15.12.1. Company Overview
- 15.12.2. Company Revenue
- 15.12.3. Products
- 15.12.4. Recent Developments
15.13. Agilent Technologies (US)
- 15.13.1. Company Overview
- 15.13.2. Company Revenue
- 15.13.3. Products
- 15.13.4. Recent Developments
15.13. PerkinElmer (US)
- 15.13.1. Company Overview
- 15.13.2. Company Revenue
- 15.13.3. Products
- 15.13.4. Recent Developments
15.15. Lonza (Switzerland)
- 15.15.1. Company Overview
- 15.15.2. Company Revenue
- 15.15.3. Products
- 15.15.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies